Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension

Alice Huertas(Université Paris-Saclay), Marc Humbert(Inserm)

European Respiratory Journal

February 23, 2012

10.1183/09031936.00159911

Cited by 120

Related Papers

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

|European Heart Journal|2022|3.6k

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

|Allergy|2004|1.1k

Pathologic assessment of vasculopathies in pulmonary hypertension

|Journal of the American College of Cardiology|2004|713

New Formula for Predicting Mean Pulmonary Artery Pressure Using Systolic Pulmonary Artery Pressure

|CHEST Journal|2004|497

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

|Nature Communications|2018|382